2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines - PubMed (original) (raw)

Practice Guideline

. 2019 Jun 25;73(24):e285-e350.

doi: 10.1016/j.jacc.2018.11.003. Epub 2018 Nov 10.

Neil J Stone, Alison L Bailey, Craig Beam, Kim K Birtcher, Roger S Blumenthal, Lynne T Braun, Sarah de Ferranti, Joseph Faiella-Tommasino, Daniel E Forman, Ronald Goldberg, Paul A Heidenreich, Mark A Hlatky, Daniel W Jones, Donald Lloyd-Jones, Nuria Lopez-Pajares, Chiadi E Ndumele, Carl E Orringer, Carmen A Peralta, Joseph J Saseen, Sidney C Smith Jr, Laurence Sperling, Salim S Virani, Joseph Yeboah

Practice Guideline

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Scott M Grundy et al. J Am Coll Cardiol. 2019.

Erratum in

No abstract available

Keywords: ACC/AHA Clinical Practice Guidelines; Guidelines; LDL-cholesterol; biomarkers; cardiovascular disease; cholesterol; coronary artery calcium score; diabetes mellitus; drug therapy; ezetimibe; hydroxymethylglutaryl-CoA reductase inhibitors/statins; hypercholesterolemia; lipids; patient compliance; pharmacological; primary prevention; proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors; risk assessment; risk reduction discussion; risk treatment discussion; secondary prevention.

PubMed Disclaimer

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources